These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24504694)

  • 1. The surprising features of the TEAD4-Vgll1 protein-protein interaction.
    Mesrouze Y; Hau JC; Erdmann D; Zimmermann C; Fontana P; Schmelzle T; Chène P
    Chembiochem; 2014 Mar; 15(4):537-42. PubMed ID: 24504694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TEAD4-YAP/TAZ protein-protein interaction: expected similarities and unexpected differences.
    Hau JC; Erdmann D; Mesrouze Y; Furet P; Fontana P; Zimmermann C; Schmelzle T; Hofmann F; Chène P
    Chembiochem; 2013 Jul; 14(10):1218-25. PubMed ID: 23780915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional similarity between the Vgll1-TEAD and the YAP-TEAD complexes.
    Pobbati AV; Chan SW; Lee I; Song H; Hong W
    Structure; 2012 Jul; 20(7):1135-40. PubMed ID: 22632831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new perspective on the interaction between the Vg/VGLL1-3 proteins and the TEAD transcription factors.
    Mesrouze Y; Aguilar G; Bokhovchuk F; Martin T; Delaunay C; Villard F; Meyerhofer M; Zimmermann C; Fontana P; Wille R; Vorherr T; Erdmann D; Furet P; Scheufler C; Schmelzle T; Affolter M; Chène P
    Sci Rep; 2020 Oct; 10(1):17442. PubMed ID: 33060790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ.
    Mesrouze Y; Meyerhofer M; Bokhovchuk F; Fontana P; Zimmermann C; Martin T; Delaunay C; Izaac A; Kallen J; Schmelzle T; Erdmann D; Chène P
    Protein Sci; 2017 Dec; 26(12):2399-2409. PubMed ID: 28960584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex.
    Kaan HYK; Chan SW; Tan SKJ; Guo F; Lim CJ; Hong W; Song H
    Sci Rep; 2017 May; 7(1):2035. PubMed ID: 28515457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and structural characterization of a TEAD mutation at the origin of Sveinsson's chorioretinal atrophy.
    Bokhovchuk F; Mesrouze Y; Izaac A; Meyerhofer M; Zimmermann C; Fontana P; Schmelzle T; Erdmann D; Furet P; Kallen J; Chène P
    FEBS J; 2019 Jun; 286(12):2381-2398. PubMed ID: 30903741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of YAP recognition by TEAD4 in the hippo pathway.
    Chen L; Chan SW; Zhang X; Walsh M; Lim CJ; Hong W; Song H
    Genes Dev; 2010 Feb; 24(3):290-300. PubMed ID: 20123908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-binding mechanism of the Hippo pathway transcription factor TEAD4.
    Shi Z; He F; Chen M; Hua L; Wang W; Jiao S; Zhou Z
    Oncogene; 2017 Jul; 36(30):4362-4369. PubMed ID: 28368398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of FAM181A and FAM181B as new interactors with the TEAD transcription factors.
    Bokhovchuk F; Mesrouze Y; Delaunay C; Martin T; Villard F; Meyerhofer M; Fontana P; Zimmermann C; Erdmann D; Furet P; Scheufler C; Schmelzle T; Chène P
    Protein Sci; 2020 Feb; 29(2):509-520. PubMed ID: 31697419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4.
    Li Y; Liu S; Ng EY; Li R; Poulsen A; Hill J; Pobbati AV; Hung AW; Hong W; Keller TH; Kang C
    Biochem J; 2018 Jun; 475(12):2043-2055. PubMed ID: 29760238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics simulations study of influence of Tyr422Ala mutation on transcriptional enhancer activation domain 4 (TEAD4) and transcription co-activators complexes.
    Niu RJ; Zheng QC; Zhang HX
    J Theor Biol; 2019 Jul; 472():27-35. PubMed ID: 30978352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OTUD6A orchestrates complex modulation of TEAD4-mediated transcriptional programs.
    Kim HJ; Choi Y; Lee Y; Hwangbo M; Kim J
    FEBS Lett; 2024 May; 598(9):1045-1060. PubMed ID: 38594215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Transcriptional Enhanced Associate Domains (TEADs).
    Gibault F; Sturbaut M; Bailly F; Melnyk P; Cotelle P
    J Med Chem; 2018 Jun; 61(12):5057-5072. PubMed ID: 29251924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational Design and Intramolecular Cyclization of Hotspot Peptide Segments at YAP-TEAD4 Complex Interface.
    Zhang D; He D; Pan X; Liu L
    Protein Pept Lett; 2020; 27(10):999-1006. PubMed ID: 32286937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational insights into the interaction mechanism of transcription cofactor vestigial-like protein 4 binding to TEA domain transcription factor 4 by molecular dynamics simulation and molecular mechanics generalized Born/surface area) calculation.
    Gao J; Zhang Y; Chen H; Chen Q; Feng D; Zhang L; Li C
    J Biomol Struct Dyn; 2019 Jul; 37(10):2538-2545. PubMed ID: 30051771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TEA domain family transcription factor TEAD4 represses murine adipogenesis by recruiting the cofactors VGLL4 and CtBP2 into a transcriptional complex.
    Zhang W; Xu J; Li J; Guo T; Jiang D; Feng X; Ma X; He L; Wu W; Yin M; Ge L; Wang Z; Ho MS; Zhao Y; Fei Z; Zhang L
    J Biol Chem; 2018 Nov; 293(44):17119-17134. PubMed ID: 30209132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Roles of Vestigial-Like Family Members in Tumor Development.
    Yamaguchi N
    Front Oncol; 2020; 10():1266. PubMed ID: 32793503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical properties of VGLL4 from Homo sapiens and Tgi from Drosophila melanogaster and possible biological implications.
    Mesrouze Y; Meyerhofer M; Zimmermann C; Fontana P; Erdmann D; Chène P
    Protein Sci; 2021 Sep; 30(9):1871-1881. PubMed ID: 34075638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into transcription enhancer factor 1 (TEF-1) activity from the solution structure of the TEA domain.
    Anbanandam A; Albarado DC; Nguyen CT; Halder G; Gao X; Veeraraghavan S
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17225-30. PubMed ID: 17085591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.